Skip to main content

Table 1 Baseline characteristics of study population

From: Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya

Variables
 Age in years
  Age, median (IQR) 30 (25,36)
  Age < 30, n (%) 364 (53)
  Age 30+, n (%) 323 (47)
 Parity, n (%)
  1–4 593 (85)
  More 64 (9)
  None 44 (6)
 Contraception, n (%)
  Contraceptive Injection 220 (43)
  Intrauterine Contraceptive Device (IUCD) 122 (24)
  Contraceptive Implant 99 (19)
  Oral Contraception (OC) 61 (12)
  Bilateral Tubal Ligation (BTL) 8 (2)
  Condom 5 (1)